Common Contracts
8 similar Subscription Agreement contracts by Aeluma, Inc., Augmedix, Inc., Compass Therapeutics, Inc., others
SUBSCRIPTION AGREEMENTSubscription Agreement • November 7th, 2024 • Lomond Therapeutics Holdings, Inc. • Blank checks • New York
This Subscription Agreement (this “Agreement”) has been entered into by and between the purchaser set forth on the Omnibus Signature Page hereof (the “Purchaser”) and Venetian-1 Acquisition Corp. (to be renamed “Lomond Therapeutics Holdings, Inc.” upon consummation of the Merger (as defined below)), a Delaware corporation (the “Company”), in connection with a private offering (the “Offering”) by the Company of Common Stock (as defined below).
SUBSCRIPTION AGREEMENTSubscription Agreement • August 4th, 2023 • Serve Robotics Inc. /DE/ • Blank checks • New York
This Subscription Agreement (this “Agreement”) has been entered into by and between the purchaser set forth on the Omnibus Signature Page hereof (the “Purchaser”) and Patricia Acquisition Corp. (to be renamed “Serve Robotics Inc.” upon consummation of the Merger (as defined below)), a Delaware corporation (the “Company”), in connection with the private placement offering (the “Offering”) by the Company.
SUBSCRIPTION AGREEMENTSubscription Agreement • December 23rd, 2022 • Aeluma, Inc. • Semiconductors & related devices • New York
This Subscription Agreement (this “Agreement”) has been entered into by and between the purchaser set forth on the Omnibus Signature Page hereof (the “Purchaser”) and Aeluma, Inc., a Delaware corporation (the “Company”) in connection with the private placement offering (the “Offering”) by the Company.
SUBSCRIPTION AGREEMENTSubscription Agreement • October 27th, 2021 • Laffin Acquisition Corp. • Blank checks • New York
This Subscription Agreement (this “Agreement”) has been entered into by and between the purchaser set forth on the Omnibus Signature Page hereof (the “Purchaser”) and Laffin Acquisition Corp. (to be renamed “Guerrilla RF, Inc.” upon consummation of the Merger (as defined below)), a Delaware corporation (the “Company”) in connection with the private placement offering (the “Offering”) by the Company.
SUBSCRIPTION AGREEMENTSubscription Agreement • June 28th, 2021 • Aeluma, Inc. • Blank checks • New York
This Subscription Agreement (this “Agreement”) has been entered into by and between the purchaser set forth on the Omnibus Signature Page hereof (the “Purchaser”) and Parc Investments, Inc. (to be renamed “Aeluma, Inc.” upon consummation of the Merger (as defined below)), a Delaware corporation (the “Company”) in connection with the private placement offering (the “Offering”) by the Company.
SUBSCRIPTION AGREEMENTSubscription Agreement • February 24th, 2021 • SmartKem, Inc. • Blank checks • New York
This Subscription Agreement (this “Agreement”) has been entered into by and between the purchaser set forth on the Omnibus Signature Page hereof (the “Purchaser”) and Parasol Investments Corp. (to be renamed “SmartKem, Inc.” upon consummation of the Share Exchange (as defined below)), a Delaware corporation (the “Company”) in connection with the private placement offering (the “Offering”) by the Company.
SUBSCRIPTION AGREEMENTSubscription Agreement • October 9th, 2020 • Augmedix, Inc. • Blank checks • New York
This Subscription Agreement (this “Agreement”) has been entered into by and between the purchaser set forth on the Omnibus Signature Page hereof (the “Purchaser”) and Malo Holdings Corporation (to be renamed “Augmedix, Inc.” upon consummation of the Merger (as defined below)), a Delaware corporation (the “Company”) in connection with the private placement offering (the “Offering”) by the Company.
SUBSCRIPTION AGREEMENTSubscription Agreement • June 23rd, 2020 • Compass Therapeutics, Inc. • Blank checks • New York
This Subscription Agreement (this “Agreement”) has been entered into by and between the purchaser set forth on the Omnibus Signature Page hereof (the “Purchaser”) and Olivia Ventures, Inc. (to be renamed “Compass Therapeutics, Inc.” upon consummation of the Merger (as defined below)), a Delaware corporation (the “Company”) in connection with the private placement offering (the “Offering”) by the Company.
